ZUCLOPENTHIXOL DECANOATE: 608 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
608
Total FAERS Reports
101 (16.6%)
Deaths Reported
180
Hospitalizations
608
As Primary/Secondary Suspect
30
Life-Threatening
20
Disabilities
First Report: 20050318 · Latest Report: 20250822
What Are the Most Common ZUCLOPENTHIXOL DECANOATE Side Effects?
#1 Most Reported
Drug ineffective
293 reports (48.2%)
#2 Most Reported
Sedation
284 reports (46.7%)
#3 Most Reported
Sexual dysfunction
255 reports (41.9%)
All ZUCLOPENTHIXOL DECANOATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 293 | 48.2% | 39 | 41 |
| Sedation | 284 | 46.7% | 39 | 40 |
| Sexual dysfunction | 255 | 41.9% | 39 | 2 |
| Metabolic disorder | 249 | 41.0% | 39 | 1 |
| Blood glucose increased | 246 | 40.5% | 39 | 1 |
| Dyskinesia | 246 | 40.5% | 39 | 1 |
| Anosognosia | 245 | 40.3% | 39 | 1 |
| Blood prolactin abnormal | 245 | 40.3% | 39 | 1 |
| Disturbance in social behaviour | 245 | 40.3% | 39 | 1 |
| Dystonia | 231 | 38.0% | 39 | 1 |
| Suicide attempt | 230 | 37.8% | 36 | 6 |
| Personality change | 225 | 37.0% | 39 | 1 |
| Condition aggravated | 187 | 30.8% | 36 | 25 |
| Schizophrenia | 186 | 30.6% | 43 | 16 |
| Adverse drug reaction | 107 | 17.6% | 24 | 1 |
| Insurance issue | 59 | 9.7% | 18 | 0 |
| Tardive dyskinesia | 58 | 9.5% | 3 | 31 |
| Completed suicide | 48 | 7.9% | 38 | 0 |
| Obesity | 40 | 6.6% | 0 | 25 |
| Arrhythmia | 39 | 6.4% | 2 | 27 |
Who Reports ZUCLOPENTHIXOL DECANOATE Side Effects? Age & Gender Data
Gender: 46.5% female, 53.5% male. Average age: 37.9 years. Most reports from: CA. View detailed demographics →
Is ZUCLOPENTHIXOL DECANOATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2011 | 4 | 0 | 4 |
| 2014 | 1 | 0 | 0 |
| 2015 | 8 | 3 | 6 |
| 2016 | 6 | 1 | 3 |
| 2017 | 8 | 4 | 3 |
| 2018 | 10 | 0 | 2 |
| 2019 | 13 | 1 | 6 |
| 2020 | 34 | 8 | 15 |
| 2021 | 16 | 7 | 7 |
| 2022 | 3 | 0 | 1 |
| 2023 | 3 | 0 | 3 |
| 2024 | 4 | 0 | 3 |
| 2025 | 2 | 2 | 0 |
What Is ZUCLOPENTHIXOL DECANOATE Used For?
| Indication | Reports |
|---|---|
| Schizophrenia | 313 |
| Product used for unknown indication | 156 |
| Psychotic disorder | 53 |
| Schizoaffective disorder bipolar type | 31 |
| Schizoaffective disorder | 26 |
| Obsessive-compulsive disorder | 14 |
| Bipolar disorder | 10 |
| Aggression | 6 |
ZUCLOPENTHIXOL DECANOATE vs Alternatives: Which Is Safer?
ZUCLOPENTHIXOL DECANOATE vs ZURANOLONE
ZUCLOPENTHIXOL DECANOATE vs ZYPREXA
ZUCLOPENTHIXOL DECANOATE vs ZYTIGA
ZUCLOPENTHIXOL DECANOATE vs ZYVOX
ZUCLOPENTHIXOL DECANOATE vs 5-FLUOROURACIL
ZUCLOPENTHIXOL DECANOATE vs 5-FU
ZUCLOPENTHIXOL DECANOATE vs 6-ACETYLMORPHINE
ZUCLOPENTHIXOL DECANOATE vs ABACAVIR
ZUCLOPENTHIXOL DECANOATE vs ABACAVIR\DOLUTEGRAVIR\LAMIVUDINE
ZUCLOPENTHIXOL DECANOATE vs ABACAVIR\LAMIVUDINE
Official FDA Label for ZUCLOPENTHIXOL DECANOATE
Official prescribing information from the FDA-approved drug label.